BridgeBio Pharma (BBIO) — insider trading
Health Care · NASDAQ
BridgeBio Pharma (BBIO) has 132 reported SEC Form 4 insider transactions in our data, including 40 open-market sales among the most recent 100 (latest 2026-09-17).
Recent Form 4 transactions
Showing the 100 most recent of 132 recorded transactions. See all on SEC EDGAR →
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-17 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 1,279 | $69.57 | $89.0K | Form 4 |
| 2026-09-17 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 8,721 | $69.01 | $601.9K | Form 4 |
| 2026-08-19 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 100 | $85.65 | $8.6K | Form 4 |
| 2026-08-19 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 1,800 | $84.69 | $152.4K | Form 4 |
| 2026-08-19 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 8,100 | $83.86 | $679.3K | Form 4 |
| 2026-08-18 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 1,199 | $83.77 | $100.4K | Form 4 |
| 2026-08-18 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 14,602 | $82.99 | $1.21M | Form 4 |
| 2026-08-18 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 17,279 | $82.21 | $1.42M | Form 4 |
| 2026-08-18 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 1,900 | $81.15 | $154.2K | Form 4 |
| 2026-08-16 | Apuli Maricel | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 4,714 | $79.86 | $376.5K | Form 4 |
| 2026-08-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 6,520 | — | $0 | Form 4 |
| 2026-08-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 11,554 | — | $0 | Form 4 |
| 2026-08-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 19,599 | — | $0 | Form 4 |
| 2026-08-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 33,544 | — | $0 | Form 4 |
| 2026-08-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 36,237 | $79.86 | $2.89M | Form 4 |
| 2026-08-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 6,520 | — | — | Form 4 |
| 2026-08-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 11,554 | — | — | Form 4 |
| 2026-08-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 19,599 | — | — | Form 4 |
| 2026-08-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion | 33,544 | — | — | Form 4 |
| 2026-08-16 | Trimarchi Thomas | Officer (President and CFO) | Shares withheld for taxes / exercise cost | 22,781 | $79.86 | $1.82M | Form 4 |
| 2026-07-30 | Apuli Maricel | Officer (Chief Accounting Officer) | Open-market sale | 2,000 | $80.06 | $160.1K | Form 4 |
| 2026-07-09 | Cook Jennifer E. | Director | Option exercise / conversion (derivative) | 17,167 | — | $0 | Form 4 |
| 2026-07-09 | Cook Jennifer E. | Director | Option exercise / conversion (derivative) | 112,422 | — | $0 | Form 4 |
| 2026-07-09 | Cook Jennifer E. | Director | Option exercise / conversion (derivative) | 19,000 | — | $0 | Form 4 |
| 2026-07-09 | Cook Jennifer E. | Director | Open-market sale | 112,422 | $90.00 | $10.12M | Form 4 |
| 2026-07-09 | Cook Jennifer E. | Director | Open-market sale | 36,167 | $84.00 | $3.04M | Form 4 |
| 2026-07-09 | Cook Jennifer E. | Director | Option exercise / conversion | 17,167 | $16.75 | $287.5K | Form 4 |
| 2026-07-09 | Cook Jennifer E. | Director | Option exercise / conversion | 112,422 | $29.00 | $3.26M | Form 4 |
| 2026-07-09 | Cook Jennifer E. | Director | Option exercise / conversion | 19,000 | $8.45 | $160.6K | Form 4 |
| 2026-07-09 | Ellis Andrea | Director | Option exercise / conversion (derivative) | 17,167 | — | $0 | Form 4 |
| 2026-07-09 | Ellis Andrea | Director | Open-market sale | 17,167 | $84.00 | $1.44M | Form 4 |
| 2026-07-09 | Ellis Andrea | Director | Option exercise / conversion | 17,167 | $16.75 | $287.5K | Form 4 |
| 2026-06-24 | Cook Jennifer E. | Director | Option exercise / conversion (derivative) | 17,167 | — | $0 | Form 4 |
| 2026-06-24 | Cook Jennifer E. | Director | Option exercise / conversion (derivative) | 20,000 | — | $0 | Form 4 |
| 2026-06-24 | Cook Jennifer E. | Director | Open-market sale | 37,167 | $70.00 | $2.60M | Form 4 |
| 2026-06-24 | Cook Jennifer E. | Director | Option exercise / conversion | 17,167 | $16.75 | $287.5K | Form 4 |
| 2026-06-24 | Cook Jennifer E. | Director | Option exercise / conversion | 20,000 | $8.45 | $169.0K | Form 4 |
| 2026-06-23 | Valantine Hannah | Director | Open-market sale | 2,196 | $68.57 | $150.6K | Form 4 |
| 2026-06-23 | Cook Jennifer E. | Director | Open-market sale | 2,196 | $68.57 | $150.6K | Form 4 |
| 2026-06-22 | Satvat Ali J. | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | Satvat Ali J. | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | Dachille Douglas A. | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | Dachille Douglas A. | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | MCCORMICK FRANK | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | MCCORMICK FRANK | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | MOMTAZEE JAMES C | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | MOMTAZEE JAMES C | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | Hassan Fred | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | Hassan Fred | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | Ellis Andrea | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | Ellis Andrea | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | DANIELS RONALD J | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | DANIELS RONALD J | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | AGUIAR ERIC | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | AGUIAR ERIC | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | HOMCY CHARLES J | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | HOMCY CHARLES J | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | Lo Andrew | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | Lo Andrew | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | Valantine Hannah | Director | Option exercise / conversion (derivative) | 2,808 | — | $0 | Form 4 |
| 2026-06-22 | Valantine Hannah | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | Valantine Hannah | Director | Open-market sale | 2,808 | $68.00 | $190.9K | Form 4 |
| 2026-06-22 | Valantine Hannah | Director | Option exercise / conversion | 2,808 | $41.73 | $117.2K | Form 4 |
| 2026-06-22 | Valantine Hannah | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-22 | Cook Jennifer E. | Director | Grant / award / vesting (derivative) | 5,277 | — | $0 | Form 4 |
| 2026-06-22 | Cook Jennifer E. | Director | Grant / award / vesting | 3,990 | — | $0 | Form 4 |
| 2026-06-20 | HOMCY CHARLES J | Director | Shares withheld for taxes / exercise cost | 788 | $66.27 | $52.2K | Form 4 |
| 2026-06-15 | Cook Jennifer E. | Director | Option exercise / conversion (derivative) | 17,167 | — | $0 | Form 4 |
| 2026-06-15 | Cook Jennifer E. | Director | Option exercise / conversion (derivative) | 65,921 | — | $0 | Form 4 |
| 2026-06-15 | Cook Jennifer E. | Director | Open-market sale | 1,503 | $67.14 | $100.9K | Form 4 |
| 2026-06-15 | Cook Jennifer E. | Director | Open-market sale | 88,737 | $66.62 | $5.91M | Form 4 |
| 2026-06-15 | Cook Jennifer E. | Director | Option exercise / conversion | 17,167 | $16.75 | $287.5K | Form 4 |
| 2026-06-15 | Cook Jennifer E. | Director | Option exercise / conversion | 65,921 | $8.45 | $557.0K | Form 4 |
| 2026-06-05 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 4,415 | $68.96 | $304.5K | Form 4 |
| 2026-06-05 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 8,437 | $67.88 | $572.7K | Form 4 |
| 2026-06-05 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 7,148 | $67.20 | $480.3K | Form 4 |
| 2026-06-05 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 4,416 | $68.96 | $304.5K | Form 4 |
| 2026-06-05 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 8,437 | $67.88 | $572.7K | Form 4 |
| 2026-06-05 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 7,147 | $67.20 | $480.3K | Form 4 |
| 2026-06-04 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 450 | $68.27 | $30.7K | Form 4 |
| 2026-06-04 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 15,921 | $67.74 | $1.08M | Form 4 |
| 2026-06-04 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 1,429 | $66.72 | $95.3K | Form 4 |
| 2026-06-04 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 2,200 | $65.72 | $144.6K | Form 4 |
| 2026-06-04 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 450 | $68.27 | $30.7K | Form 4 |
| 2026-06-04 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 15,921 | $67.74 | $1.08M | Form 4 |
| 2026-06-04 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 1,429 | $66.72 | $95.3K | Form 4 |
| 2026-06-04 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 2,200 | $65.72 | $144.6K | Form 4 |
| 2026-05-21 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 800 | $70.92 | $56.7K | Form 4 |
| 2026-05-21 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 11,250 | $70.48 | $792.9K | Form 4 |
| 2026-05-21 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 5,072 | $69.22 | $351.1K | Form 4 |
| 2026-05-21 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 6,725 | $68.30 | $459.3K | Form 4 |
| 2026-05-21 | Kumar Neil | Director, Officer (Chief Executive Officer) | Open-market sale | 2,256 | $67.57 | $152.4K | Form 4 |
| 2026-05-18 | Trimarchi Thomas | Officer (President and CFO) | Open-market sale | 3,195 | $65.95 | $210.7K | Form 4 |
| 2026-05-18 | Trimarchi Thomas | Officer (President and CFO) | Open-market sale | 10,456 | $64.82 | $677.7K | Form 4 |
| 2026-05-16 | Apuli Maricel | Officer (Chief Accounting Officer) | Shares withheld for taxes / exercise cost | 4,714 | $66.13 | $311.7K | Form 4 |
| 2026-05-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 6,519 | — | $0 | Form 4 |
| 2026-05-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 11,553 | — | $0 | Form 4 |
| 2026-05-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 19,599 | — | $0 | Form 4 |
| 2026-05-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Option exercise / conversion (derivative) | 33,544 | — | $0 | Form 4 |
| 2026-05-16 | Kumar Neil | Director, Officer (Chief Executive Officer) | Shares withheld for taxes / exercise cost | 36,236 | $66.13 | $2.40M | Form 4 |
Ask the chat about BBIO's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: BridgeBio Pharma (BBIO).
Last updated 2026-09-17 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.